Formerly The COVID Advisor — evidence-based analysis of Long COVID, immune injury, and post-viral disease
Unexpected Comeback of Hydroxychloroquine 2022
Get link
Facebook
X
Pinterest
Email
Other Apps
By
Editorial Team
-
If you have followed the development of early treatment protocols for COVID-19, you will be aware that for well over a year, Ivermectin was the central agent in the FLCCC protocol, for prevention and early treatment. Ivermectin is also part of the hospital level protocols.
Very early on, as discussed in this interview with Professor Varon, Hydroxychloroquine was present in the protocol, but it was dropped mid-2020.
This non-inclusion of Hydroxychloroquine appears to have been in part due to the bad publicity that hydroxychloroquine was suffering from, as it was targeted by the mainstream media, especially in relation to the presidential campaign in the US in 2020.
Comeback of Hydroxychloroquine
This January 19, 2022; it’s therefore a bit of a surprise to see Hydroxychloroquine to re-appear in the FLCCC prevention and early treatment protocol.
The move follows the experience of several frontline doctors who found that Hydroxychloroquine is particularly useful to deal with Omicron, in combination with Ivermectin and other agents, as indicated in the protocol.
Hydroxychloroquine and Clinical Evidence (Updated)
As of February 2022 there have been more than 30 studies of Hydroxychloroquine for early treatment with an overall average improvement of 64% as compared to the control groups.
Hydroxychloroquine (HCQ) is not effective when used very late with high dosages over a long period (RECOVERY/SOLIDARITY), effectiveness improves with earlier usage and improved dosing. Early treatment consistently shows positive effects. Negative evaluations typically ignore treatment time, often focusing on a subset of late stage studies.
Here’s a chart from c19early.comthat shows that hydroxychloroquine performs better than ivermectin when given as early treatment in terms of risk reduction of dying from COVID-19:
The overall improvement for hydroxychloroquine is better than ivermectin (for early treatment); 74 % vs 44 % in terms of death rate. Importantly, hydroxychloroquine needs to be given 'early'.
The difference in terms of effectiveness for hydroxychloroquine is distinctly different when given early vs late treatment (64% vs 20%), as shown in the summary chart below:
The evidence tracking on Hydroxychloroquine versus COVID-19 is available at c19hcq.com (constantly updated).
Base Spike Detox According to Dr Peter McCullough (in a X/Twitter post): Base Spike Detox is what I am currently using in my practice for those who have had COVID-19 multiple times, one or more of the COVID-19 vaccines, or both and believe persistent SARS-CoV-2 Spike protein could be causing problems in their body. I have arrived, based on the emerging scientific literature (1) and my clinical observation, that three OTC products are essential as a triple base combination: Nattokinase 2000 FU (100 mg) twice a day — take on an empty stomach Bromelain 500 mg once a day — take on an empty stomach Nano/Liposomal Curcumin 500 mg twice a day — take with food How long should I take this? Dr. McCullough recommends a minimum of 3 months , with many patients requiring 6–12 months or longer. Progress can be tracked via a spike protein antibody test (available through Labcorp in m...
Dr. McCullough explained (1) that the spike protein is an engineered, synthetic molecule roughly 1,200 amino acids long and resistant to degradation by the body’s normal proteases. He described how the protein was modified in laboratory settings (notably at the Wuhan Institute of Virology) to tightly bind to the ACE2 receptor, which is found throughout the body—in the lungs, heart, endothelium, kidneys, and brain. Because this receptor regulates angiotensin metabolism, older individuals with fewer ACE2 sites catabolize the spike less efficiently, leading to worse outcomes. Whether introduced by infection or by genetic‑code‑based vaccines, McCullough asserted, the persistent spike damages tissues directly and through chronic inflammation, micro‑clotting, and autoimmune cross‑reactivity. Spike Protein Protocol Personalizer Based on Dr. Peter McCullough's Base Spike Detox & FLCCC I-Recover Frameworks ⚠ Medical Disclaimer: This tool is...
Immune Systems Advisor · Integrative Medicine White Paper · Open Access Authors: OneDayMD Editorial Team (synthesis and editorial adaptation) · Original protocols: Marik P, Kory P (IMA/FLCCC, 2022–2024); McCullough PA (Cureus, 2023) · Published: March 2023 · Last updated: June 2026 · DOI: n/a (educational synthesis) Evidence Tier Key: TIER 1 RCT / systematic review TIER 2 Observational / cohort TIER 3 In vitro / mechanistic TIER 4 Expert consensus / clinical observation ⚠ Medical Disclaimer — Please Read First. This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The protocols described involve supplements with significant anticoagulant activity. Always consult a licensed physician before starting, especially if you take blood thinners, are pregnant or breastfeeding, have a bleeding disorder, or...
The McCairn Protocol (Edogawa–McCairn Protocol): Overview and Mechanistic Rationale The McCairn Protocol (also referred to as the Edogawa–McCairn Protocol ) is an experimental, two-phase treatment approach promoted by Kevin McCairn in collaboration with Edogawa Hospital. It is primarily proposed for individuals with Long COVID and post-mRNA vaccine–associated syndromes , targeting hypothesized drivers such as persistent spike protein, amyloid-like fibrin microclots, autoantibodies, chronic inflammation, and associated vascular or neurological dysfunction. Phase 1: Double Filtration Plasmapheresis (DFPP) / Plasma Adsorption (“Cleansing”) Double Filtration Plasmapheresis (DFPP) is a specialized form of therapeutic apheresis currently used in parts of Asia, including Japan, for selected autoimmune, neurological, and metabolic conditions. Procedure Blood is withdrawn, often via a large-bore catheter (e.g., internal jugular access). It is passed through a dual-filtration syste...
Can you remove spike proteins from your body? Dr. Paul Marik and Dr. Pierre Kory are pleased to introduce the I-RECOVER: Post-Vaccine Treatment protocol, designed to help people who have experienced adverse symptoms after a COVID vaccine. Kory and Marik are both part of the FLCCC*, which was founded in 2020 to share early treatment protocols for COVID-19. Kory is an ICU specialist, triple board certified in internal medicine, critical care and pulmonary medicine. He now runs a private tele-health practice specializing in the treatment of COVID-19, so-called "long-COVID" and post-vaccine syndrome. *The FLCCC Alliance is now the Independent Medical Alliance Note that there are significant overlaps between the symptoms and features of long COVID/long-hauler syndrome and post-vaccine syndrome. However, a number of clinical features appear to be characteristic of post-vaccine syndrome; most notably, severe neurological symptoms appear to be more common following vaccination. To c...
A clinician-developed regimen of nattokinase, bromelain, and curcumin for clearing persistent SARS-CoV-2 spike protein — with dosing, safety guidance, monitoring, and full FAQ. Editorial Team | Originally published March 2023 | Last updated June 30, 2026 | Reviewed against published literature and Dr. McCullough's 2025 clinical updates ⚠️ Medical Disclaimer — Please Read First This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The Base Spike Detox protocol involves supplements with significant anticoagulant activity. Always consult a licensed physician before starting , especially if you are taking blood thinners, are pregnant or breastfeeding, have a bleeding disorder, or are treating a child. For a virtual consultation with a physician familiar with this protocol, vis...
America Out Loud - Our show this week is an excerpt from the BS Free MD Podcast, where Drs. May and Tim Hindmarsh speak with cardiologist and internist Dr. Peter McCullough, a leading scientist investigating long COVID and post-vaccine syndromes. The conversation dives into the evolving understanding of spike-protein–related illness, McCullough’s ground-breaking research linking persistent spike protein exposure to long-term disability, and his practical “McCullough Protocol-Based Spike Detoxification” approach. Dr. May Hindmarsh shares her personal struggle: after severe COVID infections, menopause, and hormonal treatment, her health deteriorated—with rapid heart rate, mast-cell activation, histamine sensitivity, anxiety, insomnia, and gastrointestinal distress. She later discovered her blood test showed sky-high anti–spike protein antibody levels (>12,000 U/mL on LabCorp testing). McCullough explains that such titers correlate with circulating spike protein fragments, even years ...
Introduction and Context The concept of "turbo cancer"—rapidly progressing cancers allegedly linked to COVID-19 mRNA vaccines—has gained widespread attention. A recent preprint study (July 2025) exploring transcriptomic dysregulation in individuals with new-onset adverse events or cancers following mRNA vaccination introduces preliminary molecular data that may warrant further investigation. This article critically reviews the origins of the "turbo cancer" narrative, current scientific literature including emerging molecular studies, and emphasizes the need for evidence-based analysis when considering health claims related to vaccination. This independent article aims to cut through the noise by providing a fact-based exploration of 'turbo cancer' or 'aggressive cancer'. Drawing on peer-reviewed studies, expert insights, and data from health authorities, we unpack common claims, clarify the science, and address lingering myths. Our goal is to empo...
Over the last three years, the COVID-19 pandemic has transformed almost every aspect of our lives before we've had time to stop and question it. Although no official definition exists for post-COVID-vaccine syndrome, a temporal correlation between a patient receiving a COVID-19 vaccine and beginning or worsening of clinical manifestations is sufficient to diagnose as a COVID-19 vaccine-induced injury, when the symptoms are unexplained by other concurrent causes. Dr. Paul Marik and Dr. Pierre Kory are pleased to introduce the I-RECOVER: Post-Vaccine Treatment protocol, designed to help people who have experienced adverse symptoms after a COVID vaccine. Kory and Marik are both part of the FLCCC ( The FLCCC Alliance is now the Independent Medical Alliance ), which was founded in 2020 to share early treatment protocols for COVID-19. Kory is an ICU specialist, triple board certified in internal medicine, critical care and pulmonary medicine. He now runs a priva...
⚠ Medical Disclaimer — Please Read First This article is for educational and historical reference only and does not constitute medical advice, diagnosis, or treatment. It describes a COVID-19 outpatient protocol first proposed in 2020 by the late Dr. Vladimir Zelenko, alongside what current clinical research (through 2026) shows about each component . Hydroxychloroquine and ivermectin are prescription-relevant medicines with real drug interactions and side effects; large randomized trials completed since 2021 have not shown a meaningful treatment benefit for COVID-19 (details below), and neither drug is recommended for this use by the FDA, WHO, or NIH COVID-19 Treatment Guidelines. Always consult a licensed physician before starting any supplement or medication regimen , especially if you are pregnant or breastfeeding, have a cardiac, kidney, or thyroid condition, or take other prescription medications. For a virtual consultation with a physician, visit The Wellness Company . ...
Comments
Post a Comment